CASI Pharmaceuticals (CASIF) Revenue (2022 - 2025)
CASI Pharmaceuticals' Revenue was $7.22 million in Q4 2025, down 45.9% from $13.36 million a year earlier but up 134.9% from the prior quarter.
Powered by 
Analysis
CASI Pharmaceuticals (CASIF) Revenue (2022 - 2025) Analysis & Trends
For FY2025, Revenue at CASI Pharmaceuticals came in at $20.71 million, down 27.4% from FY2024.
- Revenue has now declined for three consecutive years, though with a five-year compound annual growth rate of 6.5% (FY2020 to FY2025).
- In earlier years, Revenue was $28.54 million in FY2024 (-15.8%), $33.88 million in FY2023 (-21.4%), $43.11 million in FY2022 (+42.9%) and $30.17 million in FY2021 (+99.2%).
- Quarterly Revenue has moved between $3.08 million (Q3 2025) and $15.26 million (Q4 2022) over five years.
- Compared with a year earlier, Revenue was higher in three of the last eight quarters, with an average decline of 6.8%.
- The best year-over-year quarter for Revenue over five years was Q4 2024 (growth of 94.3%); the worst was Q3 2025 (a decline of 60.5%).
- Per Business Quant data, CASIF's Revenue in the three quarters before Q4 2025 was $3.08 million (Q3 2025), $4.18 million (Q2 2025) and $6.24 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | CASI Pharmaceuticals | 2.47 Mn | -18.36 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7.22 Mn |
| Sep 30, 2025 | 3.08 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Mar 31, 2025 | 6.24 Mn |
| Dec 31, 2024 | 13.36 Mn |
| Sep 30, 2024 | 7.79 Mn |
| Jun 30, 2024 | 3.98 Mn |
| Mar 31, 2024 | 3.41 Mn |
| Dec 31, 2023 | 6.87 Mn |
| Sep 30, 2023 | 8.84 Mn |
| Jun 30, 2023 | 9.82 Mn |
| Mar 31, 2023 | 8.35 Mn |
| Dec 31, 2022 | 15.26 Mn |
| Sep 30, 2022 | 10.21 Mn |
| Jun 30, 2022 | 8.57 Mn |
| Mar 31, 2022 | 9.06 Mn |
API Access
CASI Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=CASIF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "CASIF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=CASIF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();